Thomson Scientific, part of The Thomson Corporation and provider of information solutions to the worldwide research and business communities, has announced that three new country modules--India, Israel, and Turkey--are available in IDRAC, a global pharmaceutical regulatory intelligence database. These modules are designed to meet the regulatory information needs of companies looking to accelerate their products' entrance into the marketplace. IDRAC is updated weekly, and brings together all the information needed to monitor regulatory requirements in 47 countries and regions.
The India module contains both regulatory and explanatory documents including consolidated versions of main acts and rules, comprehensive follow-up of amendments to this legislation, plus the main regulatory guidelines and government policies; the Israel module provides current or consolidated versions of the main texts ruling the pharmaceutical profession in Israel, plus the main guidelines as well as explanatory documents covering all regulatory aspects of drug development, registration and marketing; and the Turkey module includes all relevant regulations. Explanatory Documents in the Turkey module cover Turkish legislation and main issues related to medicinal products registration, product information, clinical research, quality assurance, pharmacovigilance, advertising, pricing and reimbursement, and generics.